Concord Wealth Partners Inovio Pharmaceuticals, Inc. Transaction History

Concord Wealth Partners

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$1.44 - $3.98 $210 - $581	-146 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$2.97 - $5.2 $510 - $894	-172 Reduced 54.09%	146 $1,000
Q4 2021 Jan 21, 2022	BUY	$4.99 - $7.46 $1,037 - $1,551	208 Added 189.09%	318 $2,000
Q3 2021 Nov 09, 2021	SELL	$7.16 - $9.69 $1,825 - $2,470	-255 Reduced 69.86%	110 $1,000
Q2 2021 Jul 29, 2021	BUY	$6.23 - $10.03 $1,626 - $2,617	261 Added 250.96%	365 $3,000
Q1 2021 May 13, 2021	BUY	$8.81 - $16.96 $916 - $1,763	104 New	104 $1,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $524M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.